Pituitary Tumor Surveillance: Pathogenic Correlation

Last updated: August 19, 2024
Sponsor: Cedars-Sinai Medical Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Pituitary Disorders

Treatment

N/A

Clinical Study ID

NCT00599092
2873
2873
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity in patients harboring pituitary mass lesions of all types.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • patients with confirmed pituitary disease

Exclusion

Exclusion Criteria:

  • patients who do not have confirmed pituitary disease

Study Design

Total Participants: 1250
Study Start date:
January 01, 1997
Estimated Completion Date:
December 31, 2050

Study Description

The purpose of this study is to observe predictors of pituitary tumor recurrence and markers of persistent disease activity through computerized collection of comprehensive demographic, therapeutic, pathologic and outcome information on patients harboring pituitary mass lesions of all types.

Connect with a study center

  • Cedars-Sinai Medical Center, Pituitary Center

    Los Angeles, California 90048
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.